Literature DB >> 12174082

Using small molecules to study big questions in cellular microbiology.

Gary E Ward1, Kimberly L Carey, Nicholas J Westwood.   

Abstract

High-throughput screening of small molecules is used extensively in pharmaceutical settings for the purpose of drug discovery. In the case of antimicrobials, this involves the identification of small molecules that are significantly more toxic to the microbe than to the host. Only a small percentage of the small molecules identified in these screens have been studied in sufficient detail to explain the molecular basis of their antimicrobial effect. Rarer still are small molecule screens undertaken with the explicit goal of learning more about the biology of a particular microbe or the mechanism of its interaction with its host. Recent technological advances in small molecule synthesis and high-throughput screening have made such mechanism-directed small molecule approaches a powerful and accessible experimental option. In this article, we provide an overview of the methods and technical requirements and we discuss the potential of small molecule approaches to address important and often otherwise experimentally intractable problems in cellular microbiology.

Mesh:

Year:  2002        PMID: 12174082     DOI: 10.1046/j.1462-5822.2002.00205.x

Source DB:  PubMed          Journal:  Cell Microbiol        ISSN: 1462-5814            Impact factor:   3.715


  8 in total

1.  A small-molecule approach to studying invasive mechanisms of Toxoplasma gondii.

Authors:  Kimberly L Carey; Nicholas J Westwood; Timothy J Mitchison; Gary E Ward
Journal:  Proc Natl Acad Sci U S A       Date:  2004-05-03       Impact factor: 11.205

2.  Small-molecule inhibitors specifically targeting type III secretion.

Authors:  R Nordfelth; A M Kauppi; H A Norberg; H Wolf-Watz; M Elofsson
Journal:  Infect Immun       Date:  2005-05       Impact factor: 3.441

3.  Identification and characterization of small molecules that inhibit intracellular toxin transport.

Authors:  Jose B Saenz; Teresa A Doggett; David B Haslam
Journal:  Infect Immun       Date:  2007-06-18       Impact factor: 3.441

4.  Small-molecule inhibitors of the budded-to-hyphal-form transition in the pathogenic yeast Candida albicans.

Authors:  Kurt A Toenjes; Suzanne M Munsee; Ashraf S Ibrahim; Rachel Jeffrey; John E Edwards; Douglas I Johnson
Journal:  Antimicrob Agents Chemother       Date:  2005-03       Impact factor: 5.191

Review 5.  Chemical biology approaches for the study of apicomplexan parasites.

Authors:  Matthew A Child
Journal:  Mol Biochem Parasitol       Date:  2013-12-11       Impact factor: 1.759

6.  Inhibitors of cellular signalling are cytotoxic or block the budded-to-hyphal transition in the pathogenic yeast Candida albicans.

Authors:  Kurt A Toenjes; Benjamin C Stark; Krista M Brooks; Douglas I Johnson
Journal:  J Med Microbiol       Date:  2009-06       Impact factor: 2.472

7.  The effect of the potential PhoQ histidine kinase inhibitors on Shigella flexneri virulence.

Authors:  Xia Cai; Jian Zhang; Mingliang Chen; Yang Wu; Xueqing Wang; Jiayu Chen; Junqin Zhang; Xu Shen; Di Qu; Hualiang Jiang
Journal:  PLoS One       Date:  2011-08-10       Impact factor: 3.240

Review 8.  Small-Molecule Modulation of Lipid-Dependent Cellular Processes against Cancer: Fats on the Gunpoint.

Authors:  Aswin T Srivatsav; Manjari Mishra; Shobhna Kapoor
Journal:  Biomed Res Int       Date:  2018-08-15       Impact factor: 3.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.